These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 108745)

  • 1. Comparison of tolerance development and dependence capacities of morphine, beta-endorphin, and [D-Met2, Pro5]-enkephalinamide.
    Miglécz E; Székely JI; Dunai-Kovács Z
    Psychopharmacology (Berl); 1979 Mar; 62(1):29-34. PubMed ID: 108745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Action of enkephalin analogues and morphine on brain acetylcholine release: differential reversal by naloxone and an opiate pentapeptide.
    Jhamandas K; Sutak M
    Br J Pharmacol; 1980; 71(1):201-10. PubMed ID: 7470736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo antagonism by naloxone of morphine, beta-endorphin and a synthetic enkephalin analog.
    Székely JI; Dunai-Kovács Z; Miglécz E; Rónai AZ; Bajusz S
    J Pharmacol Exp Ther; 1978 Dec; 207(3):878-83. PubMed ID: 731437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral activating effects of opiates and opioid peptides.
    Browne RG; Segal DS
    Biol Psychiatry; 1980 Feb; 15(1):77-86. PubMed ID: 6101965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analgesic effects of intraventricular morphine and enkephalins in nondependent and morphine-dependent rats.
    Brady LS; Holtzman SG
    J Pharmacol Exp Ther; 1982 Jul; 222(1):190-7. PubMed ID: 7201020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinociceptive activity of glycosidic enkephalin analogues.
    Rodríguez RE; Rodríguez FD; Sacristán MP; Torres JL; Reig F; García Antón JM; Valencia G
    Psychopharmacology (Berl); 1990; 101(2):222-5. PubMed ID: 2349363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the analgesic effects of various opioid peptides by a newly devised intracisternal injection technique in conscious mice.
    Ueda H; Amano H; Shiomi H; Takagi H
    Eur J Pharmacol; 1979 Jun; 56(3):265-8. PubMed ID: 582583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mu and delta receptors: their role in analgesia in the differential effects of opioid peptides on analgesia.
    Vaught JL; Rothman RB; Westfall TC
    Life Sci; 1982 Apr; 30(17):1443-55. PubMed ID: 6283293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biphasic effects of a potent enkephalin analogue (D-Met2,Pro5)-enkephalinamide and morphine on locomotor activity in mice.
    Székely JI; Miglécz E; Rónai AZ
    Psychopharmacology (Berl); 1980; 71(3):299-301. PubMed ID: 6779336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electroencephalographic and behavioral tolerance to and cross-tolerance between D-Ala2-methionine-enkephalinamide and morphine in the rat.
    Tortella FC; Moreton JE; Khazan N
    J Pharmacol Exp Ther; 1979 Aug; 210(2):174-9. PubMed ID: 222892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Met-enkephalin and (D-Met2,Pro5)-enkephalinamide on the adenylate cyclase activity of rat brain.
    Wollemann M; Szebeni A; Bajusz S; Gráf L
    Neurochem Res; 1979 Oct; 4(5):627-31. PubMed ID: 492449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methionine-enkephalin antagonism and endorphin potentiation of narcotic-induced analgesia.
    Chapman DB; Hu J; Way EL
    Eur J Pharmacol; 1980 Aug; 65(4):369-77. PubMed ID: 7190925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of synthetic enkephalinamides and morphine on abstinence responses in morphine-dependent mice.
    Bhargava HN
    Pharmacol Biochem Behav; 1980 May; 12(5):645-9. PubMed ID: 7190300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin and growth hormone releasing activity of [D-Met2, Pro5]-enkephalinamide in the rat after systemic administration.
    Locatelli V; Cocchi D; Bajusz S; Spampinato S; Müller EE
    Experientia; 1978 Dec; 34(12):1650-1. PubMed ID: 729748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible regulatory role of dynorphin-(1-13) on narcotic-induced changes in naloxone efficacy.
    Tulunay FC; Jen MF; Chang JK; Loh HH; Lee NM
    Eur J Pharmacol; 1981 Dec; 76(2-3):235-9. PubMed ID: 6277644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro effects of a synethetic enkephalin analogue (D-Met2,Pro5)-enkephalinamide on the hypothalamus-pituitary--testis function in rats.
    Vermes I; Szontágh L; Telegdy G
    Neurosci Lett; 1979 Feb; 11(2):201-4. PubMed ID: 379712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphine and [D-Met2,Pro5]enkephalinamide do not show specific neuroleptic activity.
    Sineger E; Horváth K; Miglécz E; Tarnawa I; Andrási F; Székely JI
    Eur J Pharmacol; 1982 Jun; 80(4):359-68. PubMed ID: 6125401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different types of opioid receptors mediating analgesia induced by morphine, DAMGO, DPDPE, DADLE and beta-endorphin in mice.
    Suh HH; Tseng LF
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Jul; 342(1):67-71. PubMed ID: 1976234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (D-Met2,Pro5)-enkephalinamide-induced blockade of ovulation and its reversal by naloxone in the rat.
    Köves K; Marton J; Molnár J; Halász B
    Neuroendocrinology; 1981 Feb; 32(2):82-6. PubMed ID: 6782500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opiate agonists inhibit neurogenic plasma extravasation in the rat.
    Barthó L; Szolcsányi J
    Eur J Pharmacol; 1981 Jul; 73(1):101-4. PubMed ID: 6172279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.